Garcia-Pupo L, Crouzier L, Bencomo-Martinez A, Meunier J, Morilleau A, Delprat B
Acta Pharm Sin B. 2024; 14(10):4345-4359.
PMID: 39525570
PMC: 11544189.
DOI: 10.1016/j.apsb.2024.06.013.
Wang T, Jia H
Int J Mol Sci. 2023; 24(15).
PMID: 37569401
PMC: 10418732.
DOI: 10.3390/ijms241512025.
Voronin M, Abramova E, Verbovaya E, Vakhitova Y, Seredenin S
Int J Mol Sci. 2023; 24(1).
PMID: 36614266
PMC: 9820882.
DOI: 10.3390/ijms24010823.
Du M, Jiang T, He S, Cheng B, Zhang X, Li L
Cells. 2023; 12(1).
PMID: 36611988
PMC: 9818229.
DOI: 10.3390/cells12010197.
Kim S, Coukos R, Gao F, Krainc D
Neuron. 2022; 110(15):2386-2408.
PMID: 35561676
PMC: 9357093.
DOI: 10.1016/j.neuron.2022.04.020.
Revisiting the sigma-1 receptor as a biological target to treat affective and cognitive disorders.
Salaciak K, Pytka K
Neurosci Biobehav Rev. 2021; 132:1114-1136.
PMID: 34736882
PMC: 8559442.
DOI: 10.1016/j.neubiorev.2021.10.037.
Brain-derived neurotrophic factor for high-throughput evaluation of selective Sigma-1 receptor ligands.
Dalwadi D, Kim S, Schetz J, Schreihofer D, Kim S
J Pharmacol Toxicol Methods. 2021; 113:107129.
PMID: 34678430
PMC: 9358981.
DOI: 10.1016/j.vascn.2021.107129.
Sigma-1R Protects Retinal Ganglion Cells in Optic Nerve Crush Model for Glaucoma.
Li L, He S, Liu Y, Yorio T, Ellis D
Invest Ophthalmol Vis Sci. 2021; 62(10):17.
PMID: 34406331
PMC: 8375012.
DOI: 10.1167/iovs.62.10.17.
PRE-084 as a tool to uncover potential therapeutic applications for selective sigma-1 receptor activation.
Motawe Z, Abdelmaboud S, Cuevas J, Breslin J
Int J Biochem Cell Biol. 2020; 126:105803.
PMID: 32668330
PMC: 7484451.
DOI: 10.1016/j.biocel.2020.105803.
Sigma-1 receptor activity in primary sensory neurons is a critical driver of neuropathic pain.
Shin S, Wang F, Qiu C, Itson-Zoske B, Hogan Q, Yu H
Gene Ther. 2020; 29(1-2):1-15.
PMID: 32424233
PMC: 7671947.
DOI: 10.1038/s41434-020-0157-5.
Isolation and Synthesis of Veranamine, an Antidepressant Lead from the Marine Sponge .
Kochanowska-Karamyan A, Araujo H, Zhang X, El-Alfy A, Carvalho P, Avery M
J Nat Prod. 2020; 83(4):1092-1098.
PMID: 32227883
PMC: 11187827.
DOI: 10.1021/acs.jnatprod.9b01107.
Mutational Analysis of Sigma-1 Receptor's Role in Synaptic Stability.
Ryskamp D, Zhemkov V, Bezprozvanny I
Front Neurosci. 2019; 13:1012.
PMID: 31607852
PMC: 6761230.
DOI: 10.3389/fnins.2019.01012.
Experimental Pharmacology in Transgenic Rodent Models of Alzheimer's Disease.
Cuello A, Hall H, Do Carmo S
Front Pharmacol. 2019; 10:189.
PMID: 30886583
PMC: 6409318.
DOI: 10.3389/fphar.2019.00189.
Modulation of the sigma-1 receptor-IRE1 pathway is beneficial in preclinical models of inflammation and sepsis.
Rosen D, Seki S, Fernandez-Castaneda A, Beiter R, Eccles J, Woodfolk J
Sci Transl Med. 2019; 11(478).
PMID: 30728287
PMC: 6936250.
DOI: 10.1126/scitranslmed.aau5266.
A Report of Rabbit Syndrome Who Benefited from Sigma 1 Agonist Fluvoxamine.
Albayrak Y, Beyazyuz M, Abbak O, Altindag E
Clin Psychopharmacol Neurosci. 2019; 17(1):134-138.
PMID: 30690950
PMC: 6361034.
DOI: 10.9758/cpn.2019.17.1.134.
Cholinesterase inhibitor rivastigmine enhances nerve growth factor-induced neurite outgrowth in PC12 cells via sigma-1 and sigma-2 receptors.
Terada K, Migita K, Matsushima Y, Sugimoto Y, Kamei C, Matsumoto T
PLoS One. 2018; 13(12):e0209250.
PMID: 30557385
PMC: 6296549.
DOI: 10.1371/journal.pone.0209250.
Cause or compensation?-Altered neuronal Ca handling in Huntington's disease.
Mackay J, Nassrallah W, Raymond L
CNS Neurosci Ther. 2018; 24(4):301-310.
PMID: 29427371
PMC: 6489756.
DOI: 10.1111/cns.12817.
Sigma-1 Receptor Agonists Induce Oxidative Stress in Mitochondria and Enhance Complex I Activity in Physiological Condition but Protect Against Pathological Oxidative Stress.
Goguadze N, Zhuravliova E, Morin D, Mikeladze D, Maurice T
Neurotox Res. 2017; 35(1):1-18.
PMID: 29127580
DOI: 10.1007/s12640-017-9838-2.
The Role of Sigma-1 Receptor, an Intracellular Chaperone in Neurodegenerative Diseases.
Penke B, Fulop L, Szucs M, Frecska E
Curr Neuropharmacol. 2017; 16(1):97-116.
PMID: 28554311
PMC: 5771390.
DOI: 10.2174/1570159X15666170529104323.
The sigma-1 receptor mediates the beneficial effects of pridopidine in a mouse model of Huntington disease.
Ryskamp D, Wu J, Geva M, Kusko R, Grossman I, Hayden M
Neurobiol Dis. 2016; 97(Pt A):46-59.
PMID: 27818324
PMC: 5214572.
DOI: 10.1016/j.nbd.2016.10.006.